Intracellular recycling: The key to surviving potent anti-cancer drugs

byTokyo Medical and Dental UniversityER-phagy alleviates anthracycline cardiotoxicity. Credit: Department of Cardiovascular Medicine, TMDUA cell contains many specialized subunits, called organe

Updated on: January 10,2024

Intracellular recycling: The key to surviving potent anti-cancer drugs

byTokyo Medical and Dental UniversityER-phagy alleviates anthracycline cardiotoxicity. Credit: Department of Cardiovascular Medicine, TMDUA cell contains many specialized subunits, called organe

Updated on:January 10,2024

Old drugs offer new ways of treating bowel cancer

byUniversity of AucklandCredit: CC0 Public DomainOld medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found.&quot

Updated on: December 26,2023

Old drugs offer new ways of treating bowel cancer

byUniversity of AucklandCredit: CC0 Public DomainOld medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found.&quot

Updated on:December 26,2023

Warning for younger women: Be vigilant on breast cancer risk

Updated on: November 04,2024

Warning for younger women: Be vigilant on breast cancer risk

Updated on:November 04,2024

AI can be used to detect and grade prostate cancer

byKarolinska InstitutetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Karolinska Institutet in Sw

Updated on: December 22,2023

AI can be used to detect and grade prostate cancer

byKarolinska InstitutetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Karolinska Institutet in Sw

Updated on:December 22,2023

Colonoscopies among the young are on the rise

by Ernie MundellColon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommen

Updated on: October 26,2024

Colonoscopies among the young are on the rise

by Ernie MundellColon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommen

Updated on:October 26,2024

Study finds less invasive, safer option for removing benign pancreatic tumors

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainInsulinomas are abnormal tumors, usually benign, that grow in the beta cells of the pancreas. Insulinomas make extra insuli

Updated on: April 28,2024

Study finds less invasive, safer option for removing benign pancreatic tumors

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainInsulinomas are abnormal tumors, usually benign, that grow in the beta cells of the pancreas. Insulinomas make extra insuli

Updated on:April 28,2024

Shorter MRI exam effectively detects cancer in dense breasts

Updated on: June 15,2025

Shorter MRI exam effectively detects cancer in dense breasts

Updated on:June 15,2025

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Updated on: December 22,2023

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Updated on:December 22,2023

Drugs for treating breast cancer in women are effective and well tolerated in men

byEuropean Society for Medical OncologyThere is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the la

Updated on: December 18,2023

Drugs for treating breast cancer in women are effective and well tolerated in men

byEuropean Society for Medical OncologyThere is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the la

Updated on:December 18,2023

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

In a recent study published in the journalAntioxidants, researchers discuss the potential role of melatonin in regulating deoxyribonucleic acid (DNA) methylation.Study:Melatonin: A P

Updated on: October 28,2023

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

In a recent study published in the journalAntioxidants, researchers discuss the potential role of melatonin in regulating deoxyribonucleic acid (DNA) methylation.Study:Melatonin: A P

Updated on:October 28,2023

Olaparib maintenance extends PFS by estimated three years in advanced ovarian cancer

byEuropean Society for Medical OncologyTwo-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in pro

Updated on: December 18,2023

Olaparib maintenance extends PFS by estimated three years in advanced ovarian cancer

byEuropean Society for Medical OncologyTwo-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in pro

Updated on:December 18,2023

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on: December 22,2023

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on:December 22,2023